US FDA panel votes against use of Novo Nordisk’s weekly insulin in type 1 diabetes patients
(Reuters) – A panel of independent experts to the U.S. health regulator on Friday voted against the use of Novo Nordisk’s weekly insulin in patients [more…]
(Reuters) – A panel of independent experts to the U.S. health regulator on Friday voted against the use of Novo Nordisk’s weekly insulin in patients [more…]
By Yuvraj Malik (Reuters) – Shares of Dell Technologies hit a record high on Friday amid a rally in companies working on generative artificial intelligence [more…]
(Reuters) -GameStop made nearly $933.4 million by selling 45 million shares, the struggling videogame retailer said on Friday, sending its shares up 15% after the [more…]
(Reuters) – Anglo American was pressed by key shareholders including BlackRock to extend talks with BHP Group over its proposed 38.6 billion pound ($49.18 billion) [more…]
By America Hernandez and Benjamin Mallet PARIS (Reuters) -Shareholders in French oil and gas major TotalEnergies largely backed the company’s strategy and its CEO on [more…]
By Hadeel Al Sayegh and Federico Maccioni DUBAI (Reuters) -Saudi Arabia is planning a multi-billion-dollar share sale in energy giant Aramco as soon as June [more…]
By Patrick Wingrove (Reuters) -Eli Lilly said on Friday it has invested another $5.3 billion in its new Lebanon, Indiana manufacturing plant, more than doubling [more…]
By Milana Vinn (Reuters) – Google parent Alphabet’s potential acquisition of HubSpot, a U.S. marketing software maker with a market value of $31 billion, would [more…]
By Chuck Mikolajczak NEW YORK (Reuters) -U.S. stocks ended lower on Thursday, even as a strong revenue forecast for Nvidia fueled a surge in its [more…]
(Reuters) – Boeing said on Thursday the planemaker has updated its workforce training for new hires for manufacturing and quality after pausing it in late [more…]